Humacyte, Inc. (HUMAW) SEC Filings — 2025
17 SEC filings for Humacyte, Inc. (HUMAW) in 2025.
Filings
- Humacyte, Inc. Files 8-K: Material Agreement and Exhibits — 8-K · Dec 16, 2025
- Humacyte, Inc. 8-K Filing — 8-K · Dec 15, 2025
- Humacyte, Inc. Terminates Material Definitive Agreement — 8-K · Nov 26, 2025
- Humacyte, Inc. Files 8-K on Financials — 8-K · Nov 12, 2025
- Humacyte Narrows Q3 Loss, Boosted by Revenue and Liability Adjustments — 10-Q · Nov 12, 2025
- Humacyte, Inc. Files 8-K for Material Agreement — 8-K · Oct 7, 2025
- Humacyte Files 8-K, Nasdaq Listings Confirmed — 8-K · Sep 18, 2025
- Humacyte Reports No Revenue, Relies on Capital Raises for Clinical Progress — 10-Q · Aug 11, 2025
- Humacyte, Inc. Files 8-K on Shareholder Votes & Financials — 8-K · Jun 11, 2025
- Humacyte Q1 2025 Revenue Flat, Expenses Stable — 10-Q · May 13, 2025
- Humacyte Files 2025 Proxy Statement — DEF 14A · Apr 29, 2025
- Humacyte Files 8-K: Regulation FD & Exhibits — 8-K · Apr 18, 2025
- Humacyte, Inc. Files 2024 10-K — 10-K · Mar 31, 2025
- Humacyte, Inc. Files 8-K on Financials — 8-K · Mar 28, 2025
- Humacyte, Inc. Files 8-K Report — 8-K · Mar 27, 2025
- Humacyte, Inc. Files Material Definitive Agreement 8-K — 8-K · Mar 26, 2025
- Humacyte, Inc. Files 8-K Report — 8-K · Mar 25, 2025